European DeepTech Fundraising: Combining VC With Public and Blended Capital

TL;DR

• Deeptech fundraising often combines equity with grants, subsidies, project funding or other non-dilutive sources.
• Keep funding-source obligations separate so investors can understand restrictions, matching requirements and IP implications.
• Translate technical progress into investor milestones rather than only scientific outputs.
• Maintain one evidence room covering technology, IP, grants, milestones, financials and commercialization.

Why deeptech fundraising needs a different operating model

Deeptech investors underwrite technology risk, time-to-market and capital intensity in addition to normal startup questions. Public funding can strengthen the story, but it can also introduce milestones, eligible-cost rules, reporting duties or IP considerations that investors need to understand.

Practical workflow

1. Map the capital stack

List equity, grants, subsidies, project funding and expected future capital needs.

2. Separate obligations

Document conditions, milestones, reporting and restrictions tied to each funding source.

3. Translate technical progress

Explain how scientific or engineering milestones reduce commercial risk.

4. Prepare IP diligence

Show ownership, licenses, university relationships and employee/contractor assignments clearly.

5. Build the commercialization case

Connect technical milestones to customers, deployment, regulation and revenue.

6. Coordinate investor and public reporting

Keep evidence consistent across funding stakeholders.

What to prepare

• Technology roadmap and milestone evidence.
• IP ownership and licensing records.
• Grant agreements and reporting obligations.
• Commercialization plan and customer evidence.
• Financial model including future capital needs.
• Corporate and financing records.

Related SendNow resource: European startup fundraising workflow.

Common mistakes

• Treating grant money as unrestricted cash.
• Failing to explain public-funding obligations to investors.
• Presenting technical milestones without commercial relevance.
• Leaving university or contractor IP unclear.

External reference: European Innovation Council. This article is educational and not legal, tax or regulatory advice.

See the VDR and Microsite workflow

Frequently asked questions

Can grants replace venture capital?

Sometimes they reduce dilution or fund technical milestones, but many deeptech companies still need equity for commercialization and scale.

What do investors ask about grants?

They may ask about obligations, timing, matching requirements, eligible costs, IP effects and whether the funding changes the company's plan.

Why is IP diligence critical?

Because deeptech value often depends directly on ownership or defensible rights to the core technology.

Build a cleaner investor workflow

Use SendNow Microsites when deeper investor access needs one organized source of truth.